batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. DualityBio and BioNTech take on Enhertu in HER2 low 31 August 2023 Green light for Seagen's pivotal integrin beta-6 trial 29 August 2023 Moderna gets into Claudin18.2 21 August 2023 Merck hints at progress beyond Welireg’s approved niche 18 August 2023 Cautious support for targeting CDH6 16 August 2023 No giving up on ROR1 for Oncternal 11 August 2023 iTeos joins Roche in delaying a TIGIT readout 8 August 2023 BioNTech enters the TROP2 space 7 August 2023 Load More